Plain-English translation of NCT07234422 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Heart Failure research guide →Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This trial is testing whether selenium and coQ10 supplements—two natural compounds—can help improve outcomes for people with heart failure who are already on standard treatment. You would take the medication twice daily by mouth, and the study will follow you for about 2 years to see if it makes a difference in your symptoms and overall health.
Some research suggests that selenium and coQ10 may support heart function, but we don't yet know if adding these supplements to regular heart failure treatment actually helps patients. This trial aims to answer that question.
You likely qualify if…
You likely don't qualify if…
You will receive either the selenium and coQ10 medication or a placebo (inactive pill) mailed to your home, and you'll take it twice daily. Your routine doctor visits and heart clinic appointments will continue as usual, and the study will collect information from those visits. You'll also receive phone calls at 6 months and then once a year to check in, with an expected total follow-up of about 2 years.
AI-generated summary from trial data · Jun 10, 2026 · Not medical advice
Netherlands